These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30338502)

  • 41. [Known cardiovascular risk factors (hypertension, diabetes, hypercholesteremia): secondary and tertiary prevention in pediatric patients].
    Bonnet D; Aggoun Y
    Arch Pediatr; 2002 May; 9 Suppl 2():131s-133s. PubMed ID: 12108244
    [No Abstract]   [Full Text] [Related]  

  • 42. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The need for strict control of cardiovascular risk factors in type 2 diabetic patients].
    Viberti G
    Presse Med; 2002 Oct; 31 Spec No 2():S5-8. PubMed ID: 12356004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T
    Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cardiovascular prevention in a change of era].
    Vanuzzo D; Giampaoli S; Fedele F; Mercuro G; Gulizia MM; Romeo F; Gabrielli D; Di Lenarda A
    G Ital Cardiol (Rome); 2017; 18(7):541-546. PubMed ID: 28714996
    [No Abstract]   [Full Text] [Related]  

  • 47. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personalizing Treatment: Between Primary and Secondary Prevention.
    Blaha MJ
    Am J Cardiol; 2016 Sep; 118(6 Suppl):4A-12A. PubMed ID: 27620358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
    Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of hypercholesterolemia in patients with acute coronary syndrome: current mechanisms and future perspectives].
    Lettino M
    G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):31S-7. PubMed ID: 27312021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
    Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.
    Singh RB; Rastogi SS; Rao PV; Das S; Madhu SV; Das AK; Sahay BK; Fuse SM; Beegom R; Sainani GS; Shah NA
    J Cardiovasc Risk; 1997 Jun; 4(3):201-8. PubMed ID: 9475675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of cardiovascular secondary prevention guidelines in clinical practice: a nationwide survey in Italy.
    Perrone-Filardi P; Poli A; Ambrosio G; Proto C; Chimini C; Chiariello M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):149-53. PubMed ID: 20875948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Legacy Effect of Intensive Blood Glucose Control on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Very High Risk or Secondary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials.
    Zhang X; Liu Y; Zhang F; Li J; Tong N
    Clin Ther; 2018 May; 40(5):776-788.e3. PubMed ID: 29656857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular risk factors in perspective.
    Carruthers SG
    Can Fam Physician; 1993 Feb; 39():309-14. PubMed ID: 8495121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diabetes mellitus, coronary artery disease und heart disease (Update 2019)].
    Clodi M; Saely CH; Hoppichler F; Resl M; Steinwender C; Stingl H; Wascher TC; Winhofer-Stöckl Y; Sourij H
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):169-173. PubMed ID: 30980152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implications of stroke prevention trials: treatment of global risk.
    Elkind MS
    Neurology; 2005 Jul; 65(1):17-21. PubMed ID: 16009880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of diabetes management: is improvement feasible?
    Basina M; Kraemer FB
    Am J Med; 2002 Jun; 112(8):670-2. PubMed ID: 12034419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.